Ullmann Wealth Partners Group LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 21.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 964 shares of the healthcare conglomerate’s stock after selling 261 shares during the quarter. Ullmann Wealth Partners Group LLC’s holdings in UnitedHealth Group were worth $301,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Bayforest Capital Ltd grew its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group during the 1st quarter valued at approximately $42,000. Copia Wealth Management acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC lifted its holdings in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of research firms have commented on UNH. Wells Fargo & Company reduced their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Bank of America increased their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Barclays raised their price target on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Finally, Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $358.95.
UnitedHealth Group Stock Up 0.6%
Shares of UNH stock opened at $336.72 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $304.96 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 2.20 and a beta of 0.45. The business’s fifty day moving average is $295.67 and its 200-day moving average is $364.42. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Quiet Period Expirations Explained
- Caterpillar Stock Hits All-Time High—Is There More Room to Run?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Berkshire-Backed Lennar Slides After Weak Q3 Earnings
- 3 Warren Buffett Stocks to Buy Now
- Analysts Turn Bullish on Hershey—Is Pepsi the Next Value Play?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.